Marten J. Poley - Erasmus Universiteit Rotterdam

Cost-Effectiveness of Neonatal Extracorporeal Membrane Oxygenation in the Netherlands 8551. Laupacis A, Feeny D, Detsky AS, TugwellPX: How attractive does a newtechnology have to be to warrantadoption and utilization? Tentativeguidelines for using clinical andeconomic evaluations. Can Med Assoc J1992; 146(4): 473-481.52. Organisation for Economic Co-operationand Development: Financing anddelivering health care: a comparativeanalysis of OECD countries. Paris:Organisation for Economic Co-operationand Development; 1987.53. Extracorporeal Life SupportOrganization: ECLS Registry Report.International summary. January, 2004.Ann Arbor, MI: Extracorporeal LifeSupport Organization; 2004.54. Cook LN: Update on extracorporealmembrane oxygenation. Paediatr RespirRev 2004; 5(Suppl A): S329-S337.55. Wilson JM, Bower LK, Thompson JE,Fauza DO, Fackler JC: ECMO inevolution: the impact of changingpatient demographics and alternativetherapies on ECMO. J Pediatr Surg 1996;31(8): 1116-1123.56. Azarow K, Messineo A, Pearl R, Filler R,Barker G, Bohn D: Congenitaldiaphragmatic hernia - a tale of twocities: the Toronto experience. J PediatrSurg 1997; 32(3): 395-400.57. O'Rourke PP, Lillehei CW, Crone RK,Vacanti JP: The effect of extracorporealmembrane oxygenation on the survivalof neonates with high-risk congenitaldiaphragmatic hernia: 45 cases from asingle institution. J Pediatr Surg 1991;26(2): 147-152.58. Wilson JM, Lund DP, Lillehei CW, VacantiJP: Congenital diaphragmatic hernia - atale of two cities: the Boston experience.J Pediatr Surg 1997; 32(3): 401-405.59. Clark RH, Kueser TJ, Walker MW,Southgate WM, Huckaby JL, Perez JA, etal: Low-dose nitric oxide therapy forpersistent pulmonary hypertension ofthe newborn. N Engl J Med 2000;342(7): 469-474.60. Colby CE, Lally KP, Hintz SR, Lally PA,Tibboel D, Moya FR, et al: Surfactantreplacement therapy on ECMO does notimprove outcome in neonates withcongenital diaphragmatic hernia. JPediatr Surg 2004; 39(11): 1632-1637.61. Davidson D, Barefield ES, Kattwinkel J,Dudell G, Damask M, Straube R, et al:Inhaled nitric oxide for the earlytreatment of persistent pulmonaryhypertension of the term newborn: arandomized, double-masked, placebocontrolled,dose-response, multicenterstudy. Pediatrics 1998; 101(3 Pt 1):325-334.62. The Neonatal Inhaled Nitric Oxide StudyGroup: Inhaled nitric oxide and hypoxicrespiratory failure in infants withcongenital diaphragmatic hernia.Pediatrics 1997; 99(6): 838-845.63. The Neonatal Inhaled Nitric Oxide StudyGroup: Inhaled nitric oxide in full-termand nearly full-term infants with hypoxicrespiratory failure. N Engl J Med 1997;336(9): 597-604.64. Lotze A, Mitchell BR, Bulas DI, Zola EM,Shalwitz RA, Gunkel JH: Multicenterstudy of surfactant (beractant) use inthe treatment of term infants withsevere respiratory failure. J Pediatr1998; 132(1): 40-47.65. Roberts JD, Fineman JR, Morin FC, ShaulPW, Rimar S, Schreiber MD, et al:Inhaled nitric oxide and persistentpulmonary hypertension of the newborn.N Engl J Med 1997; 336(9): 605-610.66. Campbell BT, Braun TM, SchumacherRE, Bartlett RH, Hirschl RB: Impact ofECMO on neonatal mortality in Michigan(1980-1999). J Pediatr Surg 2003;38(3): 290-295.67. Hintz SR, Suttner DM, Sheehan AM,Rhine WD, Van Meurs KP: Decreased useof neonatal extracorporeal membraneoxygenation (ECMO): how newtreatment modalities have affectedECMO utilization. Pediatrics 2000;106(6): 1339-1343.